Viral vaccine composition, process, and methods of use
First Claim
1. A multivalent antiviral vaccine comprising one or more heat-inactivated viral antigens, wherein at least one viral antigen is capable in producing an immune response in a host when said vaccine is administered orally at a dose that is sufficient for preventing or treating the viral disease in said host.
3 Assignments
0 Petitions
Accused Products
Abstract
A composition for treating or preventing virus-induced infections is described, along with a process of producing the composition and methods of the composition'"'"'s use. The composition comprises viral pathogen-infected cell or tissue, or malignantly or immunologically aberrant cells or tissues which has been reduced and/or denatured. The preferred composition is administered across a mucosal surface of an animal suffering or about suffer from infection. The composition is administered as preventive or therapeutic vaccine.
-
Citations
12 Claims
- 1. A multivalent antiviral vaccine comprising one or more heat-inactivated viral antigens, wherein at least one viral antigen is capable in producing an immune response in a host when said vaccine is administered orally at a dose that is sufficient for preventing or treating the viral disease in said host.
- 3. A composition for the induction of immunity to a viral pathogen in a host in need thereof, said composition comprising reduced viral pathogen formulated as an oral pill.
- 5. An immunogen formulated as an oral pill, wherein upon oral administration, said immunogen retains the ability to elicit an immune response in a host in need of immune response.
- 10. An oral composition suitable for treating or preventing a pathogen-induced infection in a host, the composition comprising a first component comprising a denatured antigen of an infection-inducing pathogen and a second component comprising a denatured tissue from a pathogen-infected host.
Specification